Log In
Print
BCIQ
Print
Print this Print this
 

Anti-CD38

  Manage Alerts
Collapse Summary General Information
Company Amorfix Life Sciences Ltd.
Description mAb against CD38 disease specific epitopes (DSEs)
Molecular Target CD38
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

Apexigen Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today